Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Goren, T.; Adar, L.; Sasson, N.; Weiss, Y.M.
    Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline (2010), J. Clin. Pharmacol., 50, 1420-1428.
    View publication on PubMed

Inhibitors

EC Number Inhibitors Comment Organism Structure
1.4.3.4 additional information MAO-B and MAO-A, clinical study, in vivo inhibitory activity, detailed overview Homo sapiens
1.4.3.4 Phenelzine
-
 Homo sapiens
1.4.3.4 rasagiline
-
 Homo sapiens
1.4.3.4 selegiline
-
 Homo sapiens

Natural Substrates/ Products (Substrates)

EC Number Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
1.4.3.4 4-tyramine + H2O + O2 Homo sapiens in vivo activity, overview 4-hydroxyphenylacetaldehyde + NH3 + H2O2
-
 ?

Organism

EC Number Organism UniProt Comment Textmining
1.4.3.4 Homo sapiens
-
-
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
1.4.3.4 4-tyramine + H2O + O2
-
 Homo sapiens 4-hydroxyphenylacetaldehyde + NH3 + H2O2
-
 ?
1.4.3.4 4-tyramine + H2O + O2 in vivo activity, overview Homo sapiens 4-hydroxyphenylacetaldehyde + NH3 + H2O2
-
 ?

Synonyms

EC Number Synonyms Comment Organism
1.4.3.4 MAO-A
-
 Homo sapiens
1.4.3.4 MAO-B
-
 Homo sapiens
1.4.3.4 monoamine oxidase-A
-
 Homo sapiens
1.4.3.4 monoamine oxidase-B
-
 Homo sapiens